Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma
Clinical trial NCT03034135 · COMPLETED
Trial details
- NCT number
- NCT03034135
- Sponsor
- Cantex Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-09
- Primary completion
- 2018-07-10
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.